Hepatitis C and renal failure

American Journal of Medicine

Volumn 107, Issue 6 SUPPL. 2, 1999, Pages 90-94

  Carithers Jr , Robert L ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; INTERFERON; VIRUS RNA;

BLOOD TRANSFUSION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DISEASE TRANSMISSION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULONEPHRITIS; GRAFT REJECTION; HEMODIALYSIS; HEPATITIS C; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER FAILURE; MORBIDITY; MORTALITY; PRIORITY JOURNAL;

EID: 0343920056     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(99)00392-7     Document Type: Conference Paper

References (45)

1. Terrault N.A., Wright T.L., Pereira B.J.G. Hepatitis C infection in the transplant recipient. Infect Dis Clin North Am. 9:1995;943-964.
2. Roth D. Hepatitis C virus the nephrologist's view . Am J Kidney Dis. 25:1995;3-16.
3. Johnson R.J., Gretch D.R., Yamabe H., et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 328:1993;465-470.
4. D'Amico G. Renal involvement in hepatitis C infection cryoglobulinemic glomerulonephritis [clinical conference] . Kidney Int. 54:1998;650-671.
5. Chan T.M., Lok A.S.F., Cheng I.K.P., Chan R.T. Prevalence of hepatitis C virus infection in hemodialysis patients a longitudinal study comparing the results of RNA and antibody assays . Hepatology. 17:1993;5-8.
6. Fabrizi F., Lunghi G., Andrulli S., et al. Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant. 12:1997;1394-1398.
7. Schreiber G.B., Busch M.P., Kleinman S.H., Korelitz J.J. The risk of transfusion-transmitted viral infections. N Engl J Med. 334:1996;1685-1690.
8. Courouc'e A.M., Bouchardeau F., Chauveau P., et al. Hepatitis C virus (HCV) infection in haemodialysed patients HCV-RNA and anti-HCV antibodies (third-generation assays) . Nephrol Dial Transplant. 10:1995;234-239.
9. Tokars J.I., Alter M.J., Favero M.S., Moyer L.A., Miller E., Bland L.A. National surveillance of dialysis associated diseases in the United States, 1993. ASAIO J. 42:1996;219-229.
10. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998;47:1-39.
11. Allander T., Medin C., Jacobson S.H., Grillner L., Persson M.A. Hepatitis C transmission in a hemodialysis unit molecular evidence for spread of virus among patients not sharing equipment . J Med Virol. 43:1994;415-419.
12. Okuda K., Hayashi H., Kobayashi S., Irie Y. Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol. 23:1995;28-31.
13. Forns X., Fern'andez L.P., Pons M., et al. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit. Nephrol Dial Transplant. 12:1997;736-740.
14. Fabrizi F., Lunghi G., Guarnori I., et al. Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients a prospective study . Nephrol Dial Transplant. 9:1994;1611-1615.
15. Rao V.K., Anderson W.R., Kasiske B.L., Dahl D.C. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med. 94:1993;241.
16. Pereira B.J., Wright T.L., Schmid C.H., Levey A.S. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group. Lancet. 345:1995;484-487.
17. Pereira B.J.G., Wright T.L., Schmid C.H., Levey A.S. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation. 60:1995;799-805.
18. Rao K.V., Ma J. Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation. 62:1996;1765-1769.
19. Pereira B.J.G., Milford E.L., Kirkman R.L., et al. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med. 327:1992;910-915.
20. Pessoa M.G., Wright T.L. Hepatitis C infection in transplantation. Clin Liver Dis. 1:1997;663-690.
21. Pereira B.J., Wright T.L., Schmid C.H., et al. Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection a U.S. National Collaborative Study . Kidney Int. 46:1994;886-892.
22. Zucker K., Cirocco R., Roth D., et al. Depletion of hepatitis C virus from procured kidneys using pulsatile perfusion preservation. Transplantation. 57:1994;832-840.
23. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 1997;26:2S-10S.
24. Farci P., Alter H.J., Govindarajan S., et al. Lack of protective immunity against reinfection with hepatitis C. Science. 258:1992;135-140.
25. Laskus T., Wang L.F., Rakela J., et al. Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology. 220:1996;171-176.
26. Johnson R.J., Gretch D.R., Couser W.G., et al. Hepatitis C virus-associated glomerulonephritis. Effect of α-interferon therapy. Kidney Int. 46:1994;1700-1704.
27. Johnson R.J., Alpers C.E., Gretch D., Yamabe H., Willson R. Renal disease and the liver. Gitlin N. The Liver and Systemic Disease. 1997;43-58 Churchill Livingstone, New York.
28. Vinel J.-P., Lamouliatte H., Cales P., et al. Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration. Gastroenterology. 102:1992;1760-1763.
29. Tarantino A., Campise M., Banfi G., et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int. 47:1995;618-623.
30. Agnello V., Chung R.T., Kaplan L.M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 327:1992;1490-1495.
31. Misiani R., Bellavita P., Fenili D., et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med. 117:1992;573-577.
32. Limaye A.P., Schmidt R.A., Glenny R.W., Davis C.L., Kowdley K.V. Successful treatment of severe hepatitis C-associated pulmonary vasculitis in a liver transplant recipient. Transplantation. 65:1998;998-1000.
33. Raptopoulou G.M., Spaia S., Garifallos A., et al. Interferon-alpha 2b treatment of chronic hepatitis C in haemodialysis patients. Nephrol Dial Transplant. 10:1995;1834-1837.
34. Izopet J., Rostaing L., Moussion F., et al. High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy. J Infect Dis. 176:1997;1614-1617.
35. Pol S., Thiers V., Carnot F., et al. Effectiveness and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C in haemodialysis patients. Nephrol Dial Transplant. 11:1996;58-61.
36. Chan T.M., Wu P.C., Lau J.Y., Lok A.S., Lai C.L., Cheng I.K. Interferon treatment for hepatitis C virus infection in patients on haemodialysis. Nephrol Dial Transplant. 12:1997;1414-1419.
37. Chan T.M., Lok A.S., Cheng I.K., Ng I.O. Chronic hepatitis C after renal transplantation. Treatment with alpha-interferon. Transplantation. 56:1993;1095-1098.
38. Ozgur O., Boyacioglu S., Telatar H., Haberal M. Recombinant alpha-interferon in renal allograft recipients with chronic hepatitis C. Nephrol Dial Transplant. 10:1995;2104-2106.
39. Rostaing L., Modesto A., Baron E., Cisterne J.M., Chabannier M.H., Durand D. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. Nephron. 74:1996;512-516.
40. Kramer P., ten-Kate F.-W., Bijnen A.B., Jeekel J., Weimar W. Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet. i:1984;989-990.
41. Ichikawa Y., Kyo M., Hanafusa T., et al. A 20-year case study of a kidney transplant recipient with chronic active hepatitis C clinical course and successful treatment for late acute rejection induced by interferon therapy . Transplantation. 65:1998;134-138.
42. Moses P.L., Krawitt E.L., Aziz W., Corwin H.L. Renal failure associated with hepatitis C virus infection. Improvement in renal function after treatment with interferon-alpha. Dig Dis Sci. 42:1997;443-446.
43. Ferri C., Marzo E., Longombardo G., et al. Interferon-α in mixed cryoglobulinemia patients a randomized, crossover-controlled trial . Blood. 81:1993;1132-1136.
44. Misiani R., Bellavita P., Fenili D., et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med. 330:1994;751-756.
45. Dammacco F., Sansonno D., Han J.H., et al. Natural interferon-α versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia a long-term, randomized, controlled study . Blood. 84:1994;3336-3343.